Gastroparesis Trial, Recruiting NCT06068114 Sponsor: Institute for Clinical and Experimental Medicine Condition: Gastroparesis
Back to Gastroparesis

Gastroparesis Trial, Recruiting

NCT06068114
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Type 1 or Type 2 diabetes for at least 3 years
  • You have been taking medication or insulin for your diabetes for at least 2 years

Who may not be able to join:

  • Your Type 2 diabetes is managed by diet alone, without any medication or insulin
  • Your diabetes is severely out of control and requires a hospital stay
  • You are currently taking more than one medication to help move food through your digestive system (confirm with trial site)
  • You are currently taking opioid painkillers (such as morphine or codeine), or you have taken them within the last 12 months
  • You have previously had surgery on your esophagus (food pipe) or major surgery on your stomach (such as removal or restructuring of part of the stomach)
  • You have a blockage in your stomach outlet or intestines caused by scarring or narrowing
  • You have a serious problem with blood clotting
  • You have enlarged veins in your esophagus or stomach, or a related stomach condition linked to liver problems
  • You have advanced liver cirrhosis (severe scarring of the liver)
  • You are pregnant or have recently given birth
  • You have, or have had, a cancerous or pre-cancerous condition in your stomach — although people who have been successfully treated and cured may still be eligible
  • You have been diagnosed with rumination syndrome or an eating disorder such as anorexia nervosa or bulimia
  • You have a systemic connective tissue disorder (a condition affecting tissues throughout the body — confirm with trial site)
  • You are unable to give your informed consent to take part in the study
  • You have any other condition that the trial doctor believes would interfere with the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institute for Clinical and Experimental Medicine
Registry
ClinicalTrials.gov
Start date
5 October 2022
Est. completion
30 June 2027

Where this trial is recruiting

🇨🇿 Czechia 🇸🇰 Slovakia

Primary endpoints

Pyloric distensibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov